핵의학

본문글자크기
  • [PLoS One.] Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer

    [PLoS One.] Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer

    아주의대 / 윤준기, 이수진*

  • 출처
    PLoS One.
  • 등재일
    2021 Jul 19
  • 저널이슈번호
    16(7):e0254844. doi: 10.1371/journal.pone.0254844. eCollection 2021.
  • 내용

    바로가기  >

    Abstract
    Purpose: To evaluate the feasibility of using skeletal muscle mass (SMM) at C3 (C3 SMM) as a diagnostic marker for sarcopenia in head and neck cancer (HNC) patients.

    Methods: We evaluated 165 HNC patients and 42 healthy adults who underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans. The paravertebral muscle area at C3 and skeletal muscle area at L3 were measured by CT. Pearson's correlation was used to assess the relationship between L3 and C3 SMMs. The prediction model for L3 SMM was developed by multiple linear regression. Then the correlation and the agreement between actual and predicted L3 SMMs were assessed. To evaluate the diagnostic value of C3 SMM for sarcopenia, the receiver operating characteristics (ROC) curves were analyzed.

    Results: Of the 165 HNC patients, 61 (37.0%) were sarcopenic and 104 (63.0%) were non-sarcopenic. A very strong correlation was found between L3 SMM and C3 SMM in both healthy adults (r = 0.864) and non-sarcopenic patients (r = 0.876), while a fair association was found in sarcopenic patients (r = 0.381). Prediction model showed a very strong correlation between actual SMM and predicted L3 SMM in both non-sarcopenic patients and healthy adults (r > 0.9), whereas the relationship was moderate in sarcopenic patients (r = 0.7633). The agreement between two measurements was good for healthy subjects and non-sarcopenic patients, while it was poor for sarcopenic patients. On ROC analysis, predicted L3 SMM showed poor diagnostic accuracy for sarcopenia.

    Conclusions: A correlation between L3 and C3 SMMs was weak in sarcopenic patients. A prediction model also showed a poor diagnostic accuracy. Therefore, C3 SMM may not be a strong predictor for L3 SMM in sarcopenic patients with HNC.

     

    사진설명: 건강한 성인, 근감소증이 없는 환자에서는 C3 SMM과 L3 SMM의 상관관계가 매우 강하지만, 근감소증이 있는 환자에서는 그 관계가 약해짐

     

    Affiliations

    Joon-Kee Yoon  1 , Jeon Yeob Jang  2 , Young-Sil An  1 , Su Jin Lee  1
    1 Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine, Suwon, Republic of Korea.
    2 Department of Otolaryngology, Ajou University School of Medicine, Suwon, Republic of Korea.

  • 연구소개
    근감소증은 종양환자에서 중요한 예후인자로 알려져 있으며, 임상에서는 CT에서 L3 spine level의 근육량(L3 SMM)을 측정하여 평가하는 방법을 일반적으로 사용하고 있습니다. 두경부암 환자에서 C3 spine level의 근육량(C3 SMM)과 L3 SMM이 상관관계가 높음을 보고한 연구들이 있지만, 근감소증이 있는 환자와 없는 환자에서의 분석연구는 없었습니다. 따라서, 본 연구에서는 근감소증이 있는 두경부암 환자에서 C3 SMM이 근감소증의 진단마커로 사용가능할지 PET/CT를 이용하여 평가해보았습니다. 건강한 성인과 근감소증이 없는 환자에서는 C3 SMM과 L3 SMM의 상관관계가 매우 강했지만, 근감소증이 있는 두경부암 환자에서는 fair association을 보였습니다. 예측모델을 이용한 평가에서도 건강한 성인과 근감소증이 없는 환자에서는 실제 근육량과 예측치가 매우 강한 상관관계를 보인 반면, 근감소증 환자에서는 그 관계가 보통이었습니다. 두 측정 사이의 일치는 근감소증이 없는 환자에서는 좋은 반면, 근감소증이 있는 환자에서는 좋지 않았습니다. 따라서 본 연구는 C3 SMM이 근감소증이 있는 두경부암 환자에서 L3 SMM의 강력한 예측인자가 될 수 없음을 보여주었습니다.
  • 덧글달기
    덧글달기
       IP : 18.226.222.12

    등록